Circulating FABP4 has recently been reported to act as an adipokine for the development of insulin resistance21, and neutralization of FABP4 with an antibody to FABP4 could be a feasible approach for the treatment of diabetes mellitus35. This evidence concerns the gene FABP4 and diabetes mellitus.